Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2003
11/13/2003US20030211609 Antisense modulation of ara70 expression
11/13/2003US20030211608 Antisense modulation of glycogen synthase kinase 3 beta expression
11/13/2003US20030211607 Antisense modulation of survivin expression
11/13/2003US20030211576 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211568 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211539 Apparatus for automated simultaneous chemical synthesis and optional purification of oligonucleotide and/or peptides on solid supports
11/13/2003US20030211527 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using thereof
11/13/2003US20030211496 Kit for calibrating solid supports/matrices associated with polynucleotide hybridization methodologies; genetic analysis
11/13/2003US20030211492 Using magnetic resonance imaging to identify and characterize nitroxide labeled nucleotide sequences
11/13/2003US20030211483 Methods for the enrichment of low-abundance polynucleotides
11/13/2003US20030211473 Cancer diagnostic method based upon DNA methylation differences
11/13/2003US20030211466 Using cells messenger RNA expression profile to diagnose infections or metabolic disorders
11/13/2003US20030211096 Detection of genes which amplification genome cells; anticancer, antitumor agent
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
11/13/2003US20030211091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003CA2524569A1 A method of regulating gene expression
11/13/2003CA2484940A1 Methods and compositions for the modification of nucleic acids
11/13/2003CA2483653A1 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/12/2003EP1361275A1 Cloned DNA polymerases from thermotoga neapolitana and mutants thereof
11/12/2003EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides
11/12/2003EP1361269A1 Delivery of gene products via mesangial cells expressing an exogenous gene
11/12/2003EP1360494A2 Improved non-luminescent substrate
11/12/2003EP1360326A2 Cell based triple readout assay systems for identifying compounds that affect transcription
11/12/2003EP1360325A2 Multiplex quantification of nucleic acids in diseased cells
11/12/2003EP1360324A2 Detection of varicella-zoster virus
11/12/2003EP1360299A2 The genome of a bifidobacterium
11/12/2003EP1360281A2 Regulation of human wee1-like serine/threonine protein kinase
11/12/2003EP1360278A2 Lipase variants
11/12/2003EP1042344B1 Conductive metal-containing nucleic acids
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003EP0847272B1 LIPOSOMAL p-ETHOXY OLIGONUCLEOTIDES
11/12/2003EP0840742A4 Systematic evolution of ligands by exponential enrichment: chemi-selex
11/12/2003EP0775203B1 Method of gene therapy using dna vectors without selection marker gene
11/12/2003EP0759759B1 P75 tnf receptor promoters
11/12/2003EP0742829B1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/12/2003CN1455814A Polynucleotide probe and primer originating in hepatitis E virus of Japanese, chips having the same, kits having the same and method for detecting thereof
11/12/2003CN1454900A Glucose and insulin response element
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003US6646184 Trichothecene-resistant transgenic plants
11/11/2003US6646118 Solid phase synthesis
11/11/2003US6646114 Especially phosphorothioate oligonucleotides, and to intermediates used in that process; solution phase synthesis having improved efficiencies and enhanced convenience and cost
11/11/2003US6645944 Antiproliferative and anticarcinogenic agents; gene therapy
11/11/2003US6645943 Method of down-regulating gene expression
11/11/2003US6645721 Detection of preferential nucleotide sequences in sample; provide nanoparticles having oligonucleotides attached, incubate with nucleotide sequence sample, detect adjustment in hybridization pattern
11/11/2003US6645717 Solid medium and process for the storage and rapid purification of nucleic acid
11/11/2003US6645716 Methods for detection of chloral hydrate in dichloroacetic acid
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003CA2092097C Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
11/06/2003WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003WO2003091426A1 Compilations of nucleic acids and arrays and methods of using them
11/06/2003WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003WO2003091402A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
11/06/2003WO2003091395A2 Inhibition of immune complex formation
11/06/2003WO2003091388A2 Polymorphic olfactory receptor genes and arrays, kits and methods utilizing them
11/06/2003WO2003091386A2 A new family of picornaviruses
11/06/2003WO2003091311A1 Monomers containing polyoxyalkylenes and polymer supports therefrom
11/06/2003WO2003091304A2 Solid supports functionalised by phosphorus dendrimers, method for preparing same and uses thereof
11/06/2003WO2003091280A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
11/06/2003WO2003091270A1 Mouse hepatitis virus detection
11/06/2003WO2003091267A1 Process for preparing oligonucleotides
11/06/2003WO2003057927A3 Detection of human papillomavirus e6 mrna
11/06/2003WO2003048179A3 Thermolabile hydroxyl protecting groups and methods of use
11/06/2003WO2003043402A3 Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
11/06/2003WO2003040395A3 Universal nucleotides for nucleic acid analysis
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003012124A3 Methods for immobilizing molecules to a solid phase and uses thereof
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003000841A3 Dye-labeled ribonucleotide triphosphates
11/06/2003WO2002102318A3 Eglin c based drugs for treatment of disease
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002062811A3 Improved methods for synthesis of oligonucleotides
11/06/2003WO2002045708A9 Use of zwitterionic polysaccharides for the specific modulation of immune processes
11/06/2003WO2002018643A9 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/06/2003WO2001044220A3 Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same
11/06/2003US20030208786 Transgenic pig containing heat shock protein 70 transgene
11/06/2003US20030208061 Labeled oligonucleotides, methods for making same, and compounds useful therefor
11/06/2003US20030208059 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208050 Nucleoside derivatives
11/06/2003US20030207841 Novel nucleoside and oligonucleotide analogues
11/06/2003US20030207825 Novel dinucleoside polyphosphates of general Formulae I, II and III, and formulations thereof which are selective ligands of the P2Y purinergic receptors. Applicants have discovered that dinucleoside polyphosphates of general Formulae I, II
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins)
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207421 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207420 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
1 ... 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 ... 899